GENE ONLINE|News &
Opinion
Blog

Ulcerative Colitis
The First and Only FDA-approved Drug for Chronic Digestive Diseases by Celltrion USA
2023-10-25
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Bristol Myers Squibb’s Ulcerative Colitis Treatment Gains Further Validation
2022-10-25
Xbiome Acquires Ulcerative Colitis Program from Assembly Biosciences
2022-04-29
Pfizer to Acquire Arena and its Immuno-Inflammatory Drug for $6.7 Billion
2021-12-14
Australia’s BiomeBank Seeks Approval for the World’s First Microbial Therapy
2021-07-04
AbbVie’s JAK1 Inhibitor Aces Ulcerative Colitis Trial, Prospers Amid Tough Regulatory Climate
2021-07-02
Immutep Announces Discontinuation of Phase 2 Ulcerative Colitis Study by GSK
2021-01-30
Bristol Myers Squibb’s Zeposia Shines in Ulcerative Colitis Trial
2020-10-13
Finch’s First Microbial Cocktail Treating Clostridium Infection Registers Positive Results
2020-06-24
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
LATEST
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
Healthcare Revolution: Leeuwenhoek Joins Hands with Key Companies and Experts at Healthcare+ Expo Taiwan 2024
2024-12-11
Protect Animal Health and Rejuvenate Bio Partner to Tackle Canine Heart Disease
2024-12-11
2024 Taiwan Healthcare+ Expo: Innovations in Five Key Industries
2024-12-11
EVENT
Scroll to Top